Trigger 1: Insulin Secretion Flashcards

1
Q

What is your normal blood glucose level (in mol/L)?

A

4-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What organ is insulin secreted from?

A

Pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which cell type is glucagon produced from?

A

Alpha cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cell type is insulin produced from?

A

Beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do the delta cells release?

A

Somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Does insulin secretion increase or decrease blood glucose?

A

Decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Does glucagon secretion increase or decrease blood glucose?

A

Increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other than being an endocrine organ, what other role does the pancreas play?

A

Produces digestive enzymes for use in the duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What percentage of the pancreas does the islets of Langerhans make up?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What two things are produced at the islets of Langerhans?

A

Insulin and glucagon (islets of Langerhans are made up of alpha and beta cells, amongst others.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which are the three main tissues that insulin acts on to lower blood glucose levels?

A

Liver, muscle and adipose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin promotes lipolysis in adipose tissue - true or false?

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What receptors does glucagon act on in the liver and what downstream signalling effect does this produce?

A

Via glucagon receptors that are GPCRs, increases cAMP and PKA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the increase in cAMP and PKA due to glucagon signalling on the liver lead to?

A

Inhibition of glycolysis and glycogenesis (i.e. decrease in glycogen production)
Stimulation of gluconeogenesis and glycogenolysis (i.e. increase in glucose production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In the action of Glucagon, does inhibition of glycolysis and glycogenesis increase or decrease glycogen production?

What effect does this have on blood sugar levels?

A

Decrease

Blood sugar increases (hormone helps to reduce hypoglycaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In the action of Glucagon, does stimulation of gluconeogenesis and glycogenolysis increase or decrease glucose production?

What effect does this have on blood sugar levels?

A

Increase

Blood sugar increases (hormone helps to reduce hypoglycaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Other than hormones, what other 3 factors can change your blood sugar levels?

A

Exercise
Illness
Stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where within the beta cells is insulin stored?

A

In granules in the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the first phase of insulin secretion in response to high blood sugar.

A

Beta cells exposed to high levels of glucose will cause immediate, high release of insulin secretion, which lasts for up to 15 minutes.

This is caused by an initial rapid but transient burst of insulin secretion. Probably due to the release of insulin from granules that were already docked at the cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the second phase of insulin secretion in response to high blood sugar.

A

If glucose remains high then insulin release is sustained for a long time in order to reduce blood glucose levels over time.

This is due to due to the release of both stored insulin and newly synthesized insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the 6 steps that lead to insulin secretion in pancreatic beta cells?

A
  1. Glucose enters the cell via GLUT-2 receptors
  2. Glucose is inverted to Glucose-Phosphate via glucokinase
  3. Glucose-6-phosphate is converted into pyruvate which can enter the krebs cycle
  4. Krebs cycle produces ATP which binds to KATP channels causing them to open and K+ efflux from the cell.
  5. Cell membrane depolarises causing Ca2+ channels to open and influx of Ca2+
  6. Increased Ca2+ inside the cell mediates insulin secretion from granules at the cell membrane.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is insulin secretion stimulated neuronally?

A

Stress increases Parasympathetic innervation
Acetylcholine is produced which acts on DAG, producing PKC
PKC stimulates insulin secretion from granules at the cell membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does sympathetic innervation decrease insulin secretion?

A

It blocks cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the role of glucokinase?

A

Sets the threshold for glucose stimulated insulin secretion- glucokinase has a low affinity for glucose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

For what phosphorylation process is gucokinase required?

A

Phosphorylation of glucose to form glucose-6-phosphate

26
Q

Finish the following 4 statements in relation to the important feature of beta cells.

  1. Glut2 has a ___ affinity for glucose
  2. _____ are highly vascularised
  3. ______ of beta cells are tightly controlled
  4. Highly _________ cells, with may unique ________ ______
A
  1. Glut2 has a low affinity for glucose
  2. Islets are highly vascularised
  3. Number of beta cells are tightly controlled
  4. Highly differentiated cells, with may unique transcription factors
27
Q

What is the definition of diabetes mellitus?

A

Hyperglycaemia due to insufficient insulin secretion.

Clinical defy nation: Fasting blood glucose over 7mmol/L

28
Q

How does the monogenic form of diabetes occur?

A

Single gene defects cause diabetes due to beta cell defects

29
Q

How does neonatal diabetes occur? (genetic basis)

A

Most common mutations are in KCNJ11 and ABCC8 (these code for proteins that for KATP channel subunits

30
Q

Is MODY monogenic or polygenic?

A

Monogenic

31
Q

What does MODY stand for?

A

Maturity onset diabetes of the young

32
Q

Does MODY present more like type 1 or type 2 diabetes?

A

Type 2

33
Q

True or false, people with type 2 diabetes usually have high levels of insulin secretion at diagnosis.

A

True

34
Q

Define type 2 diabetes

A

Hyperglycaemia due to insufficient insulin secretion

Due to a combination of increased insulin resistance and beta cell defects

Can have a very high level of insulin secretion but due to insulin resistance glucose levels remain high

35
Q

How does type 2 diabetes present?

A

Long duration- months or years
Older at diagnosis- 50s and 60s
Overweight/ obese
Strong family history
Thirst, hunger, polyuria (symptoms of high glucose)
Oral and vaginal thrush, periodontal disease
Tiredness

36
Q

Name 5 treatments for type2 diabetes

A
  1. Diet/ exercise
  2. Drugs to improve insulin sensitivity (e.g. metformin, pioglitazone)
  3. Drugs to stimulate insulin secretion (egg GLP-1 agonists, sulfonylureas)
  4. Drugs to promote glucose excretion via the kidneys (gliflozins)
  5. Insulin injections
37
Q

Define type 1 diabetes

A

Autoimmune destruction of insulin producing beta cells of the pancreas

Presence of autoantibodies and auto reactive T cells directed against islet cells or their antigenic constituents

38
Q

What ar the symptoms of type 1 diabetes (4 Ts)?

A

Toilet
Thirsty
Tired
Thinner

39
Q

What are the characteristics of type 1 diabetes?

A
Young age onset
Sudden onset - days to weeks
Thin at diagnosis
Autoantibodies and T cells present
Genetic link - MHCII, I and CTLA 4
Family history - spontaneous in 85% of cases
Insulin deficiency
Ketoacidosis
40
Q

Name 4 treatments for type 1 diabetes

A
  1. Insulin replacement therapy - injections or insulin pump
  2. Regular blood glucose monitoring
  3. Carbohydrate counting/ exercise
  4. Transplantation - islet or pancreas
41
Q

True or false, the insulin receptor is a GPCR?

A

False- its a tyrosine kinase

42
Q

What is the name of the transporter that allows glucose entry into muscle?

A

Glut4

43
Q

Which component in the beta cell sets the threshold for glucose stimulated insulin secretion?

A

Glucokinase

44
Q

True or false, glucokinase has a low affinity for glucose?

A

True

45
Q

What action does increased ATP levels have on the KATP channel in beta cells?

A

Closes them

46
Q

True or false, glucose is the only molecule that can moderate insulin secretion?

A

False

47
Q

Which second messenger does GLP-1 increase in beta cells to promote insulin secretion?

a. FA-acyl CoA
b. Gsq
c. IP3
d. DAG
e. cAMP

A

e. cAMP

48
Q

How do fatty acids stimulate insulin secretion?

a. Increasing DAG
b. Increasing ATP
c. Binding GRP40
d. All of the above

A

d. All of the above

49
Q

Which one of these transcription factors is NOT present in adult beta cells?

a. PDX-1
b. HNF1b
c. NeuroD1
d. Nkx6.1

A

b. HNF1b

50
Q

When might you suspect a diagnosis of Type 1 diabetes in children might not be correct?

A

A diagnosis of diabetes before 6 months (<1% type1)
Family history of diabetes with parenthood affactectd (2.4% of type 1)
Evidence of endogenous insulin production outside the honeymoon phase (after 3 years of diabetes with detectable C peptide (1-5% Type 1)
When pancreatic islet autoantibodies are absent, especially if measured at diagnosis (3-30% type 1)

51
Q

When might you suspect a diagnosis of Type 2 diabetes in adults might not be correct?

A

Not markedly obese or diabetic family members who are normal weight (20% type 2)
Acanthuses nigricans not detected (10% type 2)
Ethic background from a low prevalence type 2 diabetes trace e.g. European Caucasian (0-45% type 2)
No evidence of insulin resistance with fasting C peptide within the normal range (0-20% type 2)

52
Q

What are the potential challenges of using ES stem cells for treating diabetes?

A

The heterogeneity of the ES progeny is unacceptable in clinical settings
Uses viruses, transgenes and genetic modification
Difficult to generate fully functional insulin producing cells comparable with mature beta cells in vivo
Full maturation can be achieved through transplantation of the stem cell progeny in vivo

53
Q

What are the medical applications of iPS cell based generation of insulin producing cells?

A

Disease/ mutation specific beta cells for research
Personalised treatment
Replacement therapies
Correction of genetic defects
Circumvention of requirement of immunosuppressants

54
Q

What are the challenges of iPS cell based generation of insulin producing cells?

A

Creating clinically relevant numbers of mature beta cells
Time/ cost - only available for patients not responding to current treatments
Use of viruses causing random integration of pluripotency factors resulting in potential mutagenesis
Potential presence of pluripotent cells - teratoma formation

55
Q

What are the advantages of islet transplants?

A

Improve glucose control
Reduce requirement of insulin injections
Reduced hypoglycaemic events
Improved hypoglycaemic awareness

56
Q

What are the disadvantages of islet transplants?

A

High levels of cell death occur
Require several donor to achieve insulin independence
Insulin independence may not last long term
Requirement of immunotherapy to prevent rejection
Problems at site of injection

57
Q

How might current islet transplant protocols be changed to overcome these problems?

A

Whole pancreas transplantation
Animal sources of islets
Alternative sites of injection
Improved culture of islets before injection

58
Q

How are insulin analogues modified to alter their properties and why is this useful?

A

Changing the amino acid sequence will allow insulin to absorb and act more quickly, as it afflatus their normal hexameter formation around zinc which slows insulin absorption

Changing their isometric point (how the insulin binds to albumin) can increase the length of time insulin can act for

Injecting a combination of these different types of insulin throughout the day allows the patient to mimic the bodies normal insulin production (different types of insulin may be required after food/ exercise/ at different times of day etc)

59
Q

What is ‘smart’ insulin?

A

A person with type 1 diabetes would take an injection, or perhaps even a pill, of one of these insulins –enough to cover the needs of a day–and the smart insulin would circulate in the body, inactive, until blood glucose levels start to rise

eg Microneedle-array patches - these patches have many tiny needles on one surface to project into the skin. Insulin is only released at high glucose levels.

60
Q

What are the three components of the artificial pancreas?

A

Continuous glucose monitor, insulin pump and an algorithm for communication between the two

61
Q

Why is it hard to write the algorithm to connect the glucose monitor to the insulin pump in an artificial pancreas?

A

Very complicated- all sorts of factors that will affect your insulin secretion, such as exercise etc that are difficult to account for